user

Preclinical evaluation of mps1 inhibition in uterine leiomyosarcoma.

被引：0
|
作者：
Wong, Ho Shing [1 ]
Lee, Hok Yeung H. [1 ]
Tse, Ka Yu [1 ]
Mak, Tak Wah [2 ]
Ip, Philip P. C. [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Campbell Family Inst Breast Canc Res, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
980
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Breast cancer metastatic to uterine leiomyosarcoma. A case report and review of the literature
    Ricci, MD
    Pinotti, M
    Giribela, AHG
    Teixeira, LC
    Carvalho, FM
    Pinotti, JA
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (3-4) : 334 - 336
  • [22] SMOC2 as a potential biomarker with diagnostic value in uterine leiomyosarcoma.
    Cai, Chen
    Falcao, Raul
    Kokaraki, Georgia
    Souza, Jorge Estefano
    de Souza, Gustavo
    Carlson, Joseph Woodard
    Petta, Tirzah Braz
    CANCER RESEARCH, 2022, 82 (12)
  • [23] A Highly Specific Molecular Bioimaging Approach for Diagnosis of Human Uterine Leiomyosarcoma.
    Khater, Mostafa K.
    Shalaby, Shahinaz M.
    Al-Hendy, Ayman A.
    REPRODUCTIVE SCIENCES, 2016, 23 : 262A - 262A
  • [24] Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma.
    Copeland, Tabitha
    Groisberg, Roman
    Dizon, Don S.
    Elliott, Andrew
    Lagos, Galina
    Seeber, Andreas
    Von Mehren, Margaret
    Cardona, Kenneth
    Demeure, Michael J.
    Riedel, Richard F.
    Florou, Vaia
    Chou, Alexander J.
    Kumar, Abhijeet
    Modiano, Jaime
    Khushman, Moh'd M.
    D'Amato, Gina Z.
    Freire, Andrea P. Espejo
    Korn, W. Michael
    Trent, Jonathan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] The treatment of uterine leiomyosarcoma. Clinical outcomes of 18 cases and the effectiveness of chemotherapy
    Matoda, M.
    Takeshima, N.
    Nomura, H.
    Kino, M.
    Omatsu, K.
    Iwase, H.
    Umayahara, K.
    Takizawa, K.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 32 (06) : 647 - 650
  • [26] Effect of MPS1 Inhibition on Genotoxic Stress Responses in Murine Tumour Cells
    Suzuki, Motofumi
    Yamamori, Tohru
    Yasui, Hironobu
    Inanami, Osamu
    ANTICANCER RESEARCH, 2016, 36 (06) : 2783 - 2792
  • [27] Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy
    Amir Faisal
    Grace W Y Mak
    Mark D Gurden
    Cristina P R Xavier
    Simon J Anderhub
    Paolo Innocenti
    Isaac M Westwood
    Sébastien Naud
    Angela Hayes
    Gary Box
    Melanie R Valenti
    Alexis K De Haven Brandon
    Lisa O'Fee
    Jessica Schmitt
    Hannah L Woodward
    Rosemary Burke
    Rob L M vanMontfort
    Julian Blagg
    Florence I Raynaud
    Suzanne A Eccles
    Swen Hoelder
    Spiros Linardopoulos
    British Journal of Cancer, 2017, 116 : 1166 - 1176
  • [28] Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy
    Faisal, Amir
    Mak, Grace W. Y.
    Gurden, Mark D.
    Xavier, Cristina P. R.
    Anderhub, Simon J.
    Innocenti, Paolo
    Westwood, Isaac M.
    Naud, Sebastien
    Hayes, Angela
    Box, Gary
    Valenti, Melanie R.
    Brandon, Alexis K. De Haven
    O'Fee, Lisa
    Schmitt, Jessica
    Woodward, Hannah L.
    Burke, Rosemary
    vanMontfort, Rob L. M.
    Blagg, Julian
    Raynaud, Florence I.
    Eccles, Suzanne A.
    Hoelder, Swen
    Linardopoulos, Spiros
    BRITISH JOURNAL OF CANCER, 2017, 116 (09) : 1166 - 1176
  • [29] The MPS1 Family of Protein Kinases
    Liu, Xuedong
    Winey, Mark
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81, 2012, 81 : 561 - 585
  • [30] Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction
    Pinto, Barbara
    Silva, Joao P. N.
    Silva, Patricia M. A.
    Barbosa, Daniel Jose
    Sarmento, Bruno
    Tavares, Juliana Carvalho
    Bousbaa, Hassan
    PHARMACEUTICS, 2024, 16 (01)
12345